AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MESOBLAST LTD

2.500

+0.1305.49%

Volume:3.19M

Turnover:7.92M

Market Cap:3.23B

PE:-20.93

High:2.540

Open:2.400

Low:2.380

Close:2.370

52wk High:3.310

52wk Low:1.515

Shares:1.29B

Float Shares:786.49M

Volume Ratio:0.76

T/O Rate:0.41%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.119

EPS(LYR):-0.119

ROE:-18.95%

ROA:-5.37%

PB:3.82

PE(LYR):-20.94

Loading ...

Overview Company News Filings

Company Profile

Company Name:

MESOBLAST LTD

Exchange:

ASX

Establishment Date:

2004

Employees:

81

Office Location:

55 Collins Street,Level 38,Melbourne,Victoria,Australia

Website:

http://www.mesoblast.com

Zip Code:

3000

Phone:

Fax:

61 3 9639 6030

Introduction:

Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells. The company's products under the Phase III clinical trials include MSC-100-IV for steroid refractory acute graft versus host disease; MPC-150-IM for advanced heart failure; and MPC-06-ID for chronic low back pain due to degenerative disc disease. It is also developing MPC-300-IV that is in Phase II clinical trials for the treatment of biologic refractory rheumatoid arthritis, diabetic kidney diseases, and type 2 diabetic nephropathy. It operates in the United States, Australia, Singapore, the United Kingdom, and Switzerland. Mesoblast Limited has strategic partnerships with Tasly Pharmaceutical Group to offer MPC-150-IM for heart failure and MPC-25-IC for heart attacks in China; JCR Pharmaceuticals Co. Ltd. for the treatment of wound healing in patients with epidermolysis bullosa; and Grünenthal to develop and commercialize cell therapy for the treatment of chronic low back pain. The company was founded in 2004 and is headquartered in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MSB.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MSB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","market":"AU","secType":"STK","nameCN":"MESOBLAST LTD","latestPrice":2.5,"timestamp":1770700320000,"preClose":2.37,"halted":0,"volume":3194875,"delay":0,"changeRate":0.05485232067510544,"nameEN":"MESOBLAST LTD","floatShares":786490638,"shares":1290302187,"eps":-0.11945305748996085,"marketStatus":"Not Yet Opened","change":0.13,"latestTime":"02-10 16:12:00 AEDT","open":2.4,"high":2.54,"low":2.38,"amount":7918842,"amplitude":0.067511,"askPrice":2.5,"askSize":40,"bidPrice":2.49,"bidSize":3500,"shortable":3,"etf":0,"ttmEps":-0.11945305748996085,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":2.37,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":0.758619,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","floatShares":786490638,"roa":"-5.37%","roe":"-18.95%","lyrEps":-0.119409,"volumeRatio":0.758619,"shares":1290302187,"dividePrice":0,"high":2.54,"amplitude":0.067511,"preClose":2.37,"low":2.38,"week52Low":1.515,"pbRate":"3.82","psRate":"132.84","week52High":3.31,"institutionHeld":0,"latestPrice":2.5,"committee":0.977401,"eps":-0.11945305748996085,"divideRate":0,"volume":3194875,"delay":0,"ttmEps":-0.11945305748996085,"open":2.4,"prevYearClose":2.72,"prevWeekClose":2.23,"prevMonthClose":2.53,"prevQuarterClose":2.72,"fiveDayClose":2.49,"twentyDayClose":2.85,"sixtyDayClose":2.34,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSB.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-26","symbol":"MSB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSB.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":20356678,"yearFounded":2004,"employeeNum":81,"address":"55 Collins Street,Level 38,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9639 6036","officeFax":"61 3 9639 6030"},"stockCompanyDetail":{"websiteUrl":"http://www.mesoblast.com","stockEarnings":[{"period":"1week","weight":-0.0405},{"period":"1month","weight":-0.228},{"period":"3month","weight":0.026},{"period":"6month","weight":0.0216},{"period":"1year","weight":-0.2428},{"period":"ytd","weight":-0.1287}],"compareEarnings":[{"period":"1week","weight":0.008},{"period":"1month","weight":-0.0007},{"period":"3month","weight":0.0188},{"period":"6month","weight":0.0736},{"period":"1year","weight":0.2073},{"period":"ytd","weight":0.0101}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells. The company's products under the Phase III clinical trials include MSC-100-IV for steroid refractory acute graft versus host disease; MPC-150-IM for advanced heart failure; and MPC-06-ID for chronic low back pain due to degenerative disc disease. It is also developing MPC-300-IV that is in Phase II clinical trials for the treatment of biologic refractory rheumatoid arthritis, diabetic kidney diseases, and type 2 diabetic nephropathy. It operates in the United States, Australia, Singapore, the United Kingdom, and Switzerland. Mesoblast Limited has strategic partnerships with Tasly Pharmaceutical Group to offer MPC-150-IM for heart failure and MPC-25-IC for heart attacks in China; JCR Pharmaceuticals Co. Ltd. for the treatment of wound healing in patients with epidermolysis bullosa; and Grünenthal to develop and commercialize cell therapy for the treatment of chronic low back pain. The company was founded in 2004 and is headquartered in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.590909,"avgChangeRate":0.024576},{"month":2,"riseRate":0.52381,"avgChangeRate":0.044541},{"month":3,"riseRate":0.333333,"avgChangeRate":0.087679},{"month":4,"riseRate":0.52381,"avgChangeRate":0.004754},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.058648},{"month":6,"riseRate":0.714286,"avgChangeRate":0.092315},{"month":7,"riseRate":0.380952,"avgChangeRate":-0.043011},{"month":8,"riseRate":0.52381,"avgChangeRate":0.060058},{"month":9,"riseRate":0.47619,"avgChangeRate":0.001547},{"month":10,"riseRate":0.619048,"avgChangeRate":0.052152},{"month":11,"riseRate":0.571429,"avgChangeRate":0.021544},{"month":12,"riseRate":0.590909,"avgChangeRate":0.032632}],"exchange":"ASX","name":"MESOBLAST LTD","nameEN":"MESOBLAST LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MSB.AU\",market:\"AU\",,,undefined,":null}}